Loading the section…
Pharmsynthez is a pharmaceutical company that produces medicines and pharmaceutical substances — the active ingredients from which medicines are made. Its production site is located in the Leningrad Region. The shares trade under the ticker LIFE.
The production of substances is the most vulnerable part of the country's pharmaceutical chain. A finished tablet can be turned out at any plant, but the active ingredient for it is to a large extent bought abroad. A company that knows how to make the substance covers the very link where dependence on imports is greatest.
The second line of business is finished medicines, including drugs for treating cancer and rare diseases. Such medicines are bought mainly by the state under drug provision programmes, and the volume is set not by retail demand but by the budget.
The company is small in scale, so its results swing noticeably from year to year: a government contract won or lost changes the picture at once.
Active ingredients for the production of medicines.
Medicinal products, including those for complex diseases.
Research projects and the registration of new medicines.
Strengths and weaknesses describe the business itself. Opportunities and threats describe what may happen around it.
It produces medicines and pharmaceutical substances — the active ingredients from which medicines are manufactured — and also carries out its own development work.
It is the active ingredient of a medicine — the part that actually does the treating. The substance is then made into a tablet or a solution by adding auxiliary components. Most substances in the country are bought abroad.
Because a medicine cannot be made without the active ingredient, however modern the plant may be. Dependence on imported substances leaves the country's entire drug security vulnerable.